{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:18:11Z","timestamp":1790432291662,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.dmpk.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T03:26:41Z","timestamp":1515641201000},"page":"49-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Organs-on-a-chip: Current applications and consideration points for in\u00a0vitro ADME-Tox studies"],"prefix":"10.1016","volume":"33","author":[{"given":"Seiichi","family":"Ishida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2018.01.003_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrd3681","article-title":"Diagnosing the decline in pharmaceutical R&D efficiency","volume":"11","author":"Scannell","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.dmpk.2018.01.003_bib2","first-page":"12","article-title":"Adverse drug reactions - allergy? side-effect? intolerance?","volume":"42","author":"Smith","year":"2013","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.dmpk.2018.01.003_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1365-2125.2003.01875.x","article-title":"Adverse drug reactions in elderly patients","volume":"57","author":"Routledge","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2018.01.003_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/14740338.4.1.103","article-title":"Mechanistic basis of adverse drug reactions: the perils of inappropriate dose schedules","volume":"4","author":"Shah","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.dmpk.2018.01.003_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bcp.12706","article-title":"The law of mass action and the pharmacological concentration-effect curve: resolving the paradox of apparently non-dose-related adverse drug reactions","volume":"81","author":"Aronson","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2018.01.003_bib6","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.xphs.2017.05.010","article-title":"Recent progress in hepatocyte culture models and their application to the assessment of drug metabolism, transport, and toxicity in drug discovery: the value of tissue engineering for the successful development of a microphysiological system","volume":"106","author":"Tetsuka","year":"2017","journal-title":"J\u00a0Pharm Sci"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.dmpk.2018.01.003_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1528-1157.43.s.3.5.x","article-title":"Children versus adults: pharmacokinetic and adverse-effect differences","author":"Anderson","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.dmpk.2018.01.003_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12916-015-0322-7","article-title":"The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010","volume":"13","author":"Guthrie","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.dmpk.2018.01.003_bib9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/1535370214542068","article-title":"The relevance and potential roles of microphysiological systems in biology and medicine","volume":"239","author":"Wikswo","year":"2014","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.dmpk.2018.01.003_bib10","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nbt.2989","article-title":"Microfluidic organs-on-chips","volume":"32","author":"Bhatia","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.dmpk.2018.01.003_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrd4539","article-title":"Organs-on-chips at the frontiers of drug discovery","volume":"14","author":"Esch","year":"2015","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.dmpk.2018.01.003_bib12","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1039\/c3lc41017j","article-title":"Microfabricated mammalian organ systems and their integration into models of whole animals and humans","volume":"13","author":"Sung","year":"2013","journal-title":"Lab Chip"},{"key":"10.1016\/j.dmpk.2018.01.003_bib13","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1039\/C7LC90068F","article-title":"Organ-, body- and disease-on-a-chip systems","volume":"17","author":"Shuler","year":"2017","journal-title":"Lab Chip"},{"key":"10.1016\/j.dmpk.2018.01.003_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0887-2333(95)00007-U","article-title":"A\u00a0cell culture analogue of rodent physiology: application to naphthalene toxicology","volume":"9","author":"Sweeney","year":"1995","journal-title":"Toxicol In\u00a0Vitro"},{"key":"10.1016\/j.dmpk.2018.01.003_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1097-0290(19961005)52:1<45::AID-BIT5>3.0.CO;2-Z","article-title":"A\u00a0self-regulating cell culture analog device to mimic animal and human toxicological responses","volume":"52","author":"Shuler","year":"1996","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.dmpk.2018.01.003_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1117\/12.443045","article-title":"Animal on a chip: a microscale cell culture analog device for evaluating toxicological and pharmacological profiles","volume":"4560","author":"Sin","year":"2001","journal-title":"Microfluid BioMEMS"},{"key":"10.1016\/j.dmpk.2018.01.003_bib17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1021\/bp034077d","article-title":"The design and fabrication of three-chamber microscale cell culture analog devices with integrated dissolved oxygen sensors","volume":"20","author":"Sin","year":"2004","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.dmpk.2018.01.003_bib18","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1039\/C4LC00371C","article-title":"Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury","volume":"14","author":"Esch","year":"2014","journal-title":"Lab Chip"},{"issue":"Pt A","key":"10.1016\/j.dmpk.2018.01.003_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpb.2015.03.002","article-title":"Chip-based human liver-intestine and liver-skin co-cultures\u2013A first step toward systemic repeated dose substance testing in\u00a0vitro","volume":"95","author":"Maschmeyer","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.dmpk.2018.01.003_bib20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jbiotec.2015.02.002","article-title":"A\u00a0multi-organ chip co-culture of neurospheres and liver equivalents for long-term substance testing","volume":"205","author":"Materne","year":"2015","journal-title":"J\u00a0Biotechnol"},{"key":"10.1016\/j.dmpk.2018.01.003_bib21","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1039\/C5LC00392J","article-title":"A\u00a0four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents","volume":"15","author":"Maschmeyer","year":"2015","journal-title":"Lab Chip"},{"key":"10.1016\/j.dmpk.2018.01.003_bib22","doi-asserted-by":"crossref","first-page":"20030","DOI":"10.1038\/srep20030","article-title":"Multi-Organ toxicity demonstration in a functional human in\u00a0vitro system composed of four organs","volume":"6","author":"Oleaga","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.dmpk.2018.01.003_bib23","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.drudis.2013.11.020","article-title":"Drug enterohepatic circulation and disposition: constituents of systems pharmacokinetics","volume":"19","author":"Gao","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.dmpk.2018.01.003_bib24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1211\/jpp.60.5.0001","article-title":"Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation","volume":"60","author":"Fagerholm","year":"2008","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.dmpk.2018.01.003_bib25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00003088-200241100-00005","article-title":"Enterohepatic circulation: physiological, pharmacokinetic and clinical implications","volume":"41","author":"Roberts","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dmpk.2018.01.003_bib26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","article-title":"Pleiotropic roles of bile acids in metabolism","volume":"17","author":"de Aguiar Vallim","year":"2013","journal-title":"Cell Metab"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.dmpk.2018.01.003_bib27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jgh.12271","article-title":"Characteristics and diagnosis of NAFLD\/NASH","volume":"28","author":"Hashimoto","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.dmpk.2018.01.003_bib28","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.dmpk.2018.01.003_bib29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MPG.0b013e318284abb5","article-title":"Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease","volume":"56","author":"Vajro","year":"2013","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dmpk.2018.01.003_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4254\/wjh.v7.i3.425","article-title":"Gut-liver axis in liver cirrhosis: how to manage leaky gut and endotoxemia","volume":"7","author":"Fukui","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.dmpk.2018.01.003_bib31","first-page":"141","article-title":"Intestinal permeability in non-alcoholic fatty liver disease: the gut-liver axis","volume":"9","author":"Scarpellini","year":"2014","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.dmpk.2018.01.003_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.041624","article-title":"Inflammation and drug idiosyncrasy\u2013is there a connection?","volume":"307","author":"Roth","year":"2003","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.dmpk.2018.01.003_bib33","doi-asserted-by":"crossref","first-page":"22212","DOI":"10.1063\/1.3580753","article-title":"Bile canaliculi formation by aligning rat primary hepatocytes in a microfluidic device","volume":"5","author":"Nakao","year":"2011","journal-title":"Biomicrofluidics"},{"key":"10.1016\/j.dmpk.2018.01.003_bib34","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1039\/c2lc40074j","article-title":"Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow","volume":"12","author":"Kim","year":"2012","journal-title":"Lab Chip"},{"key":"10.1016\/j.dmpk.2018.01.003_bib35","first-page":"E7","article-title":"Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip","volume":"113","author":"Kim","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.dmpk.2018.01.003_bib36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1039\/C6IB00243A","article-title":"Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamics applications using integrated microphysiological systems (MPS)","volume":"9","author":"Maass","year":"2017","journal-title":"Integr Biol"},{"key":"10.1016\/j.dmpk.2018.01.003_bib37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1039\/C4IB00292J","article-title":"Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics\/pharmacodynamics modeling","volume":"7","author":"Abaci","year":"2015","journal-title":"Integr Biol (Camb)"},{"key":"10.1016\/j.dmpk.2018.01.003_bib38","doi-asserted-by":"crossref","first-page":"42296","DOI":"10.1038\/srep42296","article-title":"Functional coupling of human microphysiology systems: intestine, liver, kidney proximal tubule, blood-brain barrier and skeletal muscle","volume":"7","author":"Vernetti","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.dmpk.2018.01.003_bib39","first-page":"272","article-title":"Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing","volume":"33","author":"Marx","year":"2016","journal-title":"ALTEX"},{"key":"10.1016\/j.dmpk.2018.01.003_bib40","first-page":"95","article-title":"Good Cell Culture Practice for stem cells and stem-cell-derived models","volume":"34","author":"Pamies","year":"2017","journal-title":"ALTEX"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436718300120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436718300120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:54:09Z","timestamp":1761162849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436718300120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1347436718300120"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2018.01.003","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organs-on-a-chip: Current applications and consideration points for in\u00a0vitro ADME-Tox studies","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}